74870-7 |
IgM.kappa/IgM.lambda |
MRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgM.kappa/IgM.lambda [Mass Ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
IgM kappa (unit g/L) is divided by IgM lambda (unit: g/L) to calculate the IgM kappa/lambda-ratio. |
|
|
|
CHEM |
|
74870-7 |
|
|
|
|
Both |
|
|
|
0 |
IgM kappa/M lambda SerPl |
|
|
|
|
|
Chemistry; IgM kappa; IgM lambda; Immune globulin M; Immunoglobulin M; M lambda; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
74871-5 |
Rivaroxaban |
MCnc |
PPP |
Pt |
Qn |
Chromo |
|
ACTIVE |
Rivaroxaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
COAG |
|
74871-5 |
|
Chromo |
|
|
Both |
|
|
|
0 |
Rivaroxaban PPP Chro-mCnc |
|
|
|
|
|
Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Xarelto |
2.73 |
2.48 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
74872-3 |
21-Deoxycortisol |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
21-Deoxycortisol [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHEM |
|
74872-3 |
|
|
|
|
Both |
|
|
|
0 |
21DC SerPl-mCnc |
|
|
|
|
|
21DC; 21-DF; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
74873-1 |
Metabolic disorder being monitored |
Prid |
Bld.dot |
Pt |
Nom |
|
|
ACTIVE |
Metabolic disorder being monitored [Identifier] in DBS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
74873-1 |
|
|
|
|
Both |
|
|
|
0 |
Metabolic disorder monitored DBS |
|
|
|
|
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Identity or presence; Metabolic disorder monitored; Nominal; Point in time; Random; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
|
|
|
|
0 |
74874-9 |
Metabolic disorder therapy monitoring panel |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Metabolic disorder therapy monitoring panel - DBS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
74874-9 |
|
|
|
|
Order |
|
|
|
0 |
Metabolic disorder therapy Pnl DBS |
|
|
|
|
|
Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Metabolic disorder therapy Pnl; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; WB; Whole blood |
2.61 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
74875-6 |
Alloisoleucine^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Alloisoleucine [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74875-6 |
|
|
|
|
Both |
|
|
|
0 |
Alloisoleucine p diet DBS-sCnc |
|
|
|
|
|
After; aIle; alloIle; Allo-isoleucine; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; Maple syrup urine disease; MSUD; MSUD (Maple Syrup Urine Disease); p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74876-4 |
Arginine^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Arginine [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74876-4 |
|
|
|
|
Both |
|
|
|
0 |
Arginine p diet DBS-sCnc |
|
|
|
|
|
After; Arg; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74877-2 |
Argininosuccinate^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Argininosuccinate [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74877-2 |
|
|
|
|
Both |
|
|
|
0 |
Argininosuccinate p diet DBS-sCnc |
|
|
|
|
|
After; Argininosuccinic acid; arginosuccinate; Arginosuccinic acid; ASA; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74878-0 |
Carnitine.free (C0)^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Carnitine free (C0) [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74878-0 |
|
|
|
|
Both |
|
|
|
0 |
Carnitine Free p diet DBS-sCnc |
|
|
|
|
|
After; Blood; C0; Carnitine Free; Carnitine.total; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; FC; Filter paper; FP; FR; Level; Non-protein bound; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74879-8 |
Galactose 1 phosphate^post therapeutic diet |
MCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Galactose 1 phosphate [Mass/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
mg/dl |
|
|
|
|
|
|
CHAL |
|
74879-8 |
|
|
|
|
Both |
|
|
|
0 |
Gal1PO4 p diet DBS-mCnc |
|
|
|
|
|
After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; GAL-1-P; Gal1PO4; GAL-1-PO4; Galactose tolerance test; i; i Phos; Inorganic phosphate; Level; Mass concentration; p diet; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
7488-0 |
Mayfly basophil bound Ab |
ACnc |
Bld |
Pt |
Qn |
LHR |
|
ACTIVE |
Mayfly triggered histamine release [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7488-0 |
|
LHR |
|
|
Both |
|
|
|
0 |
Mayfly BasoBnd Ab Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Associated; Autoantibodies; Autoantibody; Baso; BasoBnd Ab; Basophil release; Basophils; Basos; Blood; bnd; Bph; Leukocyte histamine reaction; Leukocyte histamine release; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC release; Whole blood |
2.69 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
74880-6 |
Hydroxyproline^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Hydroxyproline [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74880-6 |
|
|
|
|
Both |
|
|
|
0 |
OH-Proline p diet DBS-sCnc |
|
|
|
|
|
After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Ohpro; OH-Proline; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74881-4 |
Isoleucine^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Isoleucine [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74881-4 |
|
|
|
|
Both |
|
|
|
0 |
Isoleucine p diet DBS-sCnc |
|
|
|
|
|
After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Ile; Level; Maple syrup urine disease; MSUD (Maple Syrup Urine Disease); p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74882-2 |
Leucine^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Leucine [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74882-2 |
|
|
|
|
Both |
|
|
|
0 |
Leucine p diet DBS-sCnc |
|
|
|
|
|
After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Leu; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74883-0 |
Ornithine^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Ornithine [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74883-0 |
|
|
|
|
Both |
|
|
|
0 |
Ornithine p diet DBS-sCnc |
|
|
|
|
|
After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; Orn; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74884-8 |
Valine^post therapeutic diet |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Valine [Moles/volume] in DBS --post therapeutic diet |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
74884-8 |
|
|
|
|
Both |
|
|
|
0 |
Valine p diet DBS-sCnc |
|
|
|
|
|
After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; Val; WB; Whole blood |
2.61 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74885-5 |
ERBB2 gene duplication associated observations panel |
- |
Tiss |
Pt |
- |
FISH |
|
ACTIVE |
ERBB2 gene (HER2) duplication associated observations panel - Tissue by FISH |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MOLPATH |
|
74885-5 |
|
FISH |
|
|
Order |
|
|
|
0 |
ERBB2 (HER2) Dup Pnl Tiss FISH |
|
|
|
|
|
Assoc; CD340; c-erb B2; C-ERBB-2; erb; ERB2; ERB-2; ErbB-2; ERBB2 (HER2) Dup Pnl; ERBB2 duplication; erb-b2 receptor tyrosine kinase 2; Fluorescent in situ hybridization; Genetics; HER2; HER-2; HER2 amplification; HER-2/neu; Heredity; Heritable; Inherited; MLN 19; Molecular pathology; MOLPATH; NEU; NGL; Pan; Panel.molpath; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) |
2.7 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.70: COMPONENT: Corrected the gene name based on the LOINC model to use the approved HGNC name for the gene that encodes the HER2 receptor. Also added "gene duplication associated observations" to clarify that this panel contains a set of result codes commonly reported with HER2 amplification FISH studies.; |
0 |
74886-3 |
Stigmasterol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Stigmasterol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
74886-3 |
|
|
|
|
Both |
|
|
|
0 |
Stigmasterol SerPl-sCnc |
|
|
|
|
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.48 |
2.48 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
74887-1 |
Stigmastanol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Stigmastanol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
74887-1 |
|
|
|
|
Both |
|
|
|
0 |
Stigmastanol SerPl-sCnc |
|
|
|
|
|
beta Sitostanol; Chemistry; Fucostanol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sitostanol; SR; Substance concentration |
2.48 |
2.48 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
74888-9 |
Sterols panel |
SCnc |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Sterols panel [Moles/volume] - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
74888-9 |
|
|
|
|
Order |
|
|
|
0 |
Sterols Pnl SerPl-sCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sterols Pnl; Substance Concentration |
2.5 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
Changed Component name from Phytosterols to Sterols since panel includes both sterols and phytosterols. |
0 |
74889-7 |
Phosphate |
SCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Phosphate [Moles/volume] in Saliva (oral fluid) |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
74889-7 |
|
|
|
|
Both |
|
|
|
0 |
Phosphate Sal-sCnc |
|
|
|
|
|
Chemistry; i Phos; Inorganic phosphate; Level; Oral fluid; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration |
2.48 |
2.48 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
7489-8 |
Melaleuca leucadendron basophil bound Ab |
ACnc |
Bld |
Pt |
Qn |
LHR |
|
ACTIVE |
Cajeput tree triggered histamine release [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7489-8 |
|
LHR |
|
|
Both |
|
|
|
0 |
Cajeput tree BasoBnd Ab Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Associated; Autoantibodies; Autoantibody; Baso; BasoBnd Ab; Basophil release; Basophils; Basos; Blood; bnd; Bph; Cajeput tree; Leukocyte histamine reaction; Leukocyte histamine release; Point in time; Punk tree; QNT; Quan; Quant; Quantitative; Random; t021; t21; WB; WBC release; Whole blood |
2.69 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
74890-5 |
Inositol.free/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Inositol Free/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
74890-5 |
|
|
|
|
Both |
|
|
|
0 |
Inositol Free/Creat Ur-sRto |
|
|
|
|
|
Chemistry; CR; Crea; Creat; Cyclohexane-1,2,3,4,5,6-hexol; FR; Inositol Free; Myoinositol; myo-inositol; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.48 |
2.48 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
74891-3 |
Medium-chain Acyl CoA dehydrogenase |
CCnt |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
MIN |
DefinitionDescription |
|
|
nmol/min/mg protein |
|
|
|
|
|
|
CHEM |
|
74891-3 |
|
|
|
|
Both |
|
|
|
0 |
MCAD WBC-cCnt |
|
|
|
|
|
ACAD; AcdA; Acyl CoA dehydrogenase, medium chain; Acyl CoA dehydrogenase.medium chain; Catalytic Content; Chains; Chemistry; Chn; Dehydrog; Dehyrdogenase; Leukocytes; MCAD; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.48 |
2.48 |
|
|
|
|
|
|
|
nmol/min/mg{protein} |
|
|
|
0 |
74892-1 |
Medium-chain Acyl CoA dehydrogenase |
CCnt |
Fibroblasts |
Pt |
Qn |
|
|
ACTIVE |
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
MIN |
DefinitionDescription |
|
|
nmol/min/mg protein |
|
|
|
|
|
|
CHEM |
|
74892-1 |
|
|
|
|
Both |
|
|
|
0 |
MCAD Fib-cCnt |
|
|
|
|
|
ACAD; AcdA; Acyl CoA dehydrogenase, medium chain; Acyl CoA dehydrogenase.medium chain; Catalytic Content; Chains; Chemistry; Chn; Dehydrog; Dehyrdogenase; Fib; Fibr; MCAD; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
|
|
|
|
|
|
nmol/min/mg{protein} |
|
|
|
0 |